ImmuCell Corp (ICCC)

5.14 +0.23 (+4.68%) USD  |  NASDAQ  |  May 01, 13:50
More

ImmuCell Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for ICCC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2020. Upgrade now.
Date Value
October 06, 2020 --
August 14, 2020 --
Date Value
July 13, 2020 --

Revenue Estimates for Next Quarter Range, Past 5 Years

Upgrade
Minimum
Jul 13 2020
Upgrade
Maximum
Oct 06 2020
Upgrade
Average
Upgrade
Median
Jul 13 2020

Revenue Estimates for Next Quarter Benchmarks

NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc Upgrade
Oragenics Inc Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade